title: Phosphorylation of eIF2alpha is required for mRNA translation inhibition and survival during moderate hypoxia.
abstract: OBJECTIVE
  Human tumors are characterized by temporal fluctuations in oxygen tension. The biological pathways that respond to the dynamic tumor microenvironment represent potential molecular targets for cancer therapy. Anoxic conditions result in eIF2alpha dependent inhibition of overall mRNA translation, differential gene expression, hypoxia tolerance and tumor growth. The signaling pathway which governs eIF2alpha phosphorylation has therefore emerged as a potential molecular target. In this study, we investigated the role of eIF2alpha in regulating mRNA translation and hypoxia tolerance during moderate hypoxia. Since other molecular pathways that regulate protein synthesis are frequently mutated in cancer, we also assessed mRNA translation in a panel of cell lines from different origins.
  
  
  METHODS
  Immortalized human fibroblast, transformed mouse embryo fibroblasts (MEFs) and cells from six cancer cell lines were exposed to 0.2% or 0.0% oxygen. We assayed global mRNA translation efficiency by polysome analysis, as well as proliferation and clonogenic survival. The role of eIF2alpha was assessed in MEFs harboring a homozygous inactivating mutation (S51A) as well as in U373-MG cells overexpressing GADD34 (C-term) under a tetracycline-dependent promoter. The involvement of eIF4E regulation was investigated in HeLa cells stably expressing a short hairpin RNA (shRNA) targeting 4E-BP1.
  
  
  RESULTS
  All cells investigated inhibited mRNA translation severely in response to anoxia and modestly in response to hypoxia. Two independent genetic cell models demonstrated that inhibition of mRNA translation in response to moderate hypoxia was dependent on eIF2alpha phosphorylation. Disruption of eIF2alpha phosphorylation caused sensitivity to hypoxia and anoxia.
  
  
  CONCLUSIONS
  Disruption of eIF2alpha phosphorylation is a potential target for hypoxia-directed molecular cancer therapy.
authors.affiliation: Department of Radiation Oncology (Maastro Lab), GROW Research Institute, Maastricht University, Maastricht, The Netherlands.
authors.forename: Marianne
authors.initials: M
authors.lastname: Koritzinsky
authors.forename: Kasper M A
authors.initials: KM
authors.lastname: Rouschop
authors.forename: Twan
authors.initials: T
authors.lastname: van den Beucken
authors.forename: Michaël G
authors.initials: MG
authors.lastname: Magagnin
authors.forename: Kim
authors.initials: K
authors.lastname: Savelkouls
authors.forename: Philippe
authors.initials: P
authors.lastname: Lambin
authors.forename: Bradly G
authors.initials: BG
authors.lastname: Wouters
mesh_terms: D000818:Animals; D015153:Blotting, Western; D015687:Cell Hypoxia; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000502:physiology; D015852:Eukaryotic Initiation Factor-2 / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D010766:Phosphorylation; D014176:Protein Biosynthesis / Q000502:physiology*; D012333:RNA, Messenger / Q000096:biosynthesis; D015398:Signal Transduction / Q000235:genetics
chemical_list: D015852:Eukaryotic Initiation Factor-2; D012333:RNA, Messenger